NCT06982573 The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
| NCT ID | NCT06982573 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bundang CHA Hospital |
| Condition | End-Stage Renal Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 18 participants |
| Start Date | 2025-08-06 |
| Primary Completion | 2026-02-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 18 participants in total. It began in 2025-08-06 with a primary completion date of 2026-02-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.
Eligibility Criteria
Inclusion Criteria: 1. Adults aged 19 years or older 2. Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week 3. Back pain intensity of 4 points or higher on the visual analogue scale (VAS) 4. Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) \[14\] 5. Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions Exclusion Criteria: 1. If the pain is due to trauma 2. If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability. 3. Patients with severe neurological illness (e.g. stroke, severe dementia, etc.). 4. Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection 5. Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant) 6. If there are contraindications to magnetic stimulation * Patients with implanted medical devices (e.g. pacemakers) * Metal objects are inserted into the skull * A wound on the skin at the attachment site * History of epilepsy * Cervical pain or musculoskeletal disease * Pregnant and lactating women
Contact & Investigator
Kim Minyoung, M.D., Ph.D
PRINCIPAL INVESTIGATOR
Bundang CHA Hospital
Frequently Asked Questions
Who can join the NCT06982573 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying End-Stage Renal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06982573 currently recruiting?
Yes, NCT06982573 is actively recruiting participants. Contact the research team at a230419@chamc.co.kr for enrollment information.
Where is the NCT06982573 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea.
Who is sponsoring the NCT06982573 clinical trial?
NCT06982573 is sponsored by Bundang CHA Hospital. The principal investigator is Kim Minyoung, M.D., Ph.D at Bundang CHA Hospital. The trial plans to enroll 18 participants.